These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1045 related items for PubMed ID: 24655877

  • 1. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
    Cowher MS, Grobmyer SR, Lyons J, O'Rourke C, Baynes D, Crowe JP.
    J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D, Holloway C, Shelley W, Down N, Robinson P, Sinclair S, Mirsky D, Breast Cancer Disease Site Group of Cancer Care, Ontario's Program in Evidence-Based Care.
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [Abstract] [Full Text] [Related]

  • 5. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R, Shiraishi K, Iwase S, Ohtomo K, Nakagawa K.
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK.
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J, Polgár C, Péley G, Németh G.
    Orv Hetil; 2001 Sep 09; 142(36):1941-50. PubMed ID: 11680099
    [Abstract] [Full Text] [Related]

  • 14. The evolving role of axillary lymph node dissection in the modern era of breast cancer management.
    Barry JM, Weber WP, Sacchini V.
    Surg Oncol; 2012 Jun 09; 21(2):143-5. PubMed ID: 21440434
    [Abstract] [Full Text] [Related]

  • 15. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K, Ogawa Y, Kajino C, Deguchi S, Kurihara S, Tashima T, Goto W, Nishiguchi Y, Tokunaga S, Fukushima H, Inoue T.
    Eur J Surg Oncol; 2014 Jul 09; 40(7):818-23. PubMed ID: 24768416
    [Abstract] [Full Text] [Related]

  • 16. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, Rageth C.
    Eur J Surg Oncol; 2013 Aug 09; 39(8):880-6. PubMed ID: 23735162
    [Abstract] [Full Text] [Related]

  • 17. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB.
    J Surg Oncol; 2006 Feb 01; 93(2):129-32. PubMed ID: 16425295
    [Abstract] [Full Text] [Related]

  • 18. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.
    Ann Surg Oncol; 2010 Feb 01; 17(2):552-7. PubMed ID: 19957043
    [Abstract] [Full Text] [Related]

  • 19. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N, Demir D, Bati B, Yilmaz BD, Bati Y, Çaynak ZC, Sobutay E.
    Jpn J Clin Oncol; 2012 Jul 01; 42(7):601-8. PubMed ID: 22511807
    [Abstract] [Full Text] [Related]

  • 20. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.